Need professional-grade analysis? Visit stockanalysis.com
$16.99M
N/A
84
N/A
Price Chart
Risk-Adjusted Performance
Cambridge Cognition Holdings Plc (COG) Price Performance
Cambridge Cognition Holdings Plc (COG) trades on London Stock Exchange in GBX. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at GBX36.50.
Over the past year, COG has traded between a low of GBX25.00 and a high of GBX43.50. The stock has gained 1.4% over this period. It is currently 16.1% below its 52-week high.
Cambridge Cognition Holdings Plc has a market capitalization of $16.99M.
About Cambridge Cognition Holdings Plc
Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers digital cognitive assessments, including the CANTAB cognitive assessment battery, which measures cognitive function correlated to neural networks; a voice analysis platform, an automated speech assessment tool that provides real-time scoring for cognitive performance; and high frequency testing, which detects fluctuations in brain health with short tasks over regular timepoints. It also provides electronic questionnaires and scales (eCOA), which collect neurocognitive data in a data capture system; the automated quality assurance (AQUA) solution, which analyzes the audio during the administration of central nervous system (CNS) clinical scales to detect deviations in administration and scoring; and Clinpal, a decentralized clinical trials platform. Cambridge Cognition Holdings Plc was incorporated in 2012 and is headquartered in Cambridge, the United Kingdom.
Compare Cambridge Cognition Holdings Plc
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Health Information Services
- Exchange
- London Stock Exchange
- Currency
- GBX
- Country
- United Kingdom
Financial Metrics
- Revenue (TTM)
- $9.40M
- EBITDA
- $-647,000
- Profit Margin
- -17.82%
- EPS (TTM)
- -0.04
- Book Value
- 0.06
Technical Indicators
- 52 Week High
- GBX 45.00
- 52 Week Low
- GBX 23.90
- 50 Day MA
- GBX 39.64
- 200 Day MA
- GBX 33.80
- Beta
- 0.83
Valuation
- Trailing P/E
- N/A
- Forward P/E
- 12.17
- Price/Sales
- 1.81
- Price/Book
- 5.68
- Enterprise Value
- $16.73M